Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
COA published
- Arrives Thu, Oct 22 – Tue, Oct 27Free standard shipping on orders over $100
- Free shipment protectionLost, stolen, or damaged? We replace it, on us.
- Overnight and 2-day optionsPick your speed at checkout
VIP
Cellular Peptide
Vasoactive intestinal peptide, a 28-residue neuropeptide that acts on the VPAC1 and VPAC2 receptors. It is used in research on smooth-muscle relaxation, immune regulation and circadian signaling. For in vitro laboratory research use only.
- Arrives Thu, Oct 22 – Tue, Oct 27Free standard shipping on orders over $100
- Free shipment protectionLost, stolen, or damaged? We replace it, on us.
- Overnight and 2-day optionsPick your speed at checkout
Certificate of Analysis
Third Party Tested ISO/IEC 17025 ACCREDITED
✓ Passed full QC panel
Compound Information
What is VIP?
- CAS number
- 37221-79-7
- Molecular weight
- 3,326.8 g/mol
- Amino acids
- 28
- Formula
- C147H237N43O43S
- H
- S
- D
- A
- V
- F
- T
- D
- N
- Y
- T
- R
- L
- R
- K
- Q
- M
- A
- V
- K
- K
- Y
- L
- N
- S
- I
- L
- N
- NH2
Stability information
- Protect from light
- Avoid repeated freeze-thaw cycles
Conditions apply to sealed research vials as supplied. Batch details are on the Certificate of Analysis above.
Sources & References
Peer-reviewed research
Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migration
View Source ↗Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization
View Source ↗Vasoactive intestinal peptide. Messenger in a neuroimmune axis
View Source ↗Vasoactive Intestinal Peptide: Another Player in Adipose Tissue Blood Flow Regulation?
View Source ↗Vasoactive intestinal peptide and renin secretion
View Source ↗Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions
View Source ↗Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors
View Source ↗The G Protein-Coupled Receptor, VPAC1, Mediates Vasoactive Intestinal Peptide-Dependent Functional Homeostasis of the Gut Microbiota
View Source ↗Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activity
View Source ↗Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine
View Source ↗Frequently Researched Together
Related research compounds
TB-500
Actin-binding research peptide
Epithalon
Tetrapeptide research compound
BPC-157
Body-protective compound peptide
NAD+
Cellular Peptide
KPV
Cellular Peptide
Thymosin Alpha-1
Immunomodulatory peptide
ARA-290
Cellular Peptide
PT-141
Melanocortin receptor agonist
AOD-9604
Cellular Peptide